TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06891443: Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)

Sponsor: Laboratoires Thea · Phase: PHASE3 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 32 pts

Competing Trials Overlap

12 Active Trials

Excess Burn Exposure

$3,111,504

Rescue Site Savings

+$2,074,336

Unlock Full NCT06891443 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06891443 Rescue Dossier →